---
title: "Equillium regains compliance with Nasdaq's $1.00 minimum bid price rule"
url: "https://aibio.space/news/equillium-regains-compliance-nasdaqs-1-00-minimum-bid-price-rule/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2025-09-04"
section: "Listings"
tickers: "NASDAQ:EQ"
source: "https://www.sec.gov/Archives/edgar/data/1746466/000095017025113023/eq-20250829.htm"
summary: "Nasdaq notified the company on August 29, 2025. Its shares closed at $1.00 or more for at least 10 consecutive business days."
---

By the aibio.space news desk.

Sources

- [Equillium, Inc. 8-K (2025-09-04)](https://www.sec.gov/Archives/edgar/data/1746466/000095017025113023/eq-20250829.htm)

[EQ](https://aibio.space/companies/equillium/)

2025-09-04

# Equillium regains compliance with Nasdaq's $1.00 minimum bid price rule

Tickers [EQ](https://aibio.space/companies/equillium/)

Nasdaq notified the company on August 29, 2025. Its shares closed at $1.00 or more for at least 10 consecutive business days.

## Key facts

- **Company**: Equillium, Inc. (NASDAQ: EQ)

- **News type**: Listings

- **Primary source**: [Equillium, Inc. 8-K (2025-09-04)](https://www.sec.gov/Archives/edgar/data/1746466/000095017025113023/eq-20250829.htm)

*An aerial view of the Capitol and its grounds. CC0, via rawpixel. The picture shows the field, not the companies named.*

Equillium, Inc. (Nasdaq: [EQ](https://aibio.space/companies/equillium/)) said it has regained compliance with Nasdaq's minimum bid price requirement for continued listing on The Nasdaq Capital Market.

In an [8-K filed September 4, 2025](https://www.sec.gov/Archives/edgar/data/1746466/000095017025113023/eq-20250829.htm), the La Jolla, California company said the Listing Qualifications Department of Nasdaq sent a letter on August 29, 2025 confirming compliance with Nasdaq Listing Rule 5550(a)(2). That rule requires a listed stock to keep a minimum bid price of $1.00 per share.

Equillium first received a deficiency notice on December 13, 2024, after its common stock failed to meet the $1.00 threshold. A bid price deficiency means a company's shares have closed below the exchange minimum for too long, which can lead to delisting if it is not fixed.

On June 12, 2025, Nasdaq granted the company an additional 180-day period to regain compliance. To do so, Equillium's common stock had to hold a closing bid price of $1.00 per share or more for at least 10 consecutive business days. The company said that requirement was met on August 28, 2025.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

EQ

Equillium, Inc.

NASDAQ · United States

Open the starter desk

## More in Listings

Listings

### [Propanc Biopharma faces Nasdaq delisting on bid price, plans to appeal](https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/)

Oct 29, 2026

Listings

### [Reviva asks stockholders to approve reverse split of up to 1-for-100](https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/)

Oct 29, 2026

Listings

### [Nasdaq to delist Glucotrack shares after bid price exception ends](https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/)

Oct 28, 2026

---
Source page: https://aibio.space/news/equillium-regains-compliance-nasdaqs-1-00-minimum-bid-price-rule/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Equillium regains compliance with Nasdaq's $1.00 minimum bid price rule", 2025-09-04, https://aibio.space/news/equillium-regains-compliance-nasdaqs-1-00-minimum-bid-price-rule/